PERJA, MYRVETE
PERJA, MYRVETE
Universita' degli Studi di MILANO
Safety and effectiveness of raltegravir in patients with haemophilia and anti-HIV multidrug resistance
2012 L. Mangiafico, M. Perja, F. Fusco, S. Riva, D. Mago, A. Gringeri
Ultrasonography of haemophilic arthropathy
2012 M. Perja, S. Riva, B. Grochowska, L. Mangiafico, D. Mago, A. Gringeri
Pharmacotherapy of haemophilia A
2011 A. Gringeri, M. Perja, L. Mangiafico, S. von Mackensen
Prospective cost-effectiveness study of regular continuous prophylactic replacement therapy in adults with severe hemophilia A
2008 A. Gringeri, M.S. Monzini, S. von Mackensen, M. Muça-Perja, F. Borghetti, L. Mantovani
Sequential combined bypassing therapy : a rescue option in refractory bleeds – the Italian experience
2008 A. Gringeri, E. Santagostino, M.E. Mancuso, A. Meloni, M. Muça-Perja, S.M. Siboni
Long-term safety and feasibility of arteriovenous fistulae as vascular accesses in children with haemophilia : a prospective study
2003 E. Santagostino, A. Gringeri, L. Berardinelli, C. Beretta, M. Perja, P. M. Mannucci
Identification of immunodominant epitopes in inactivated Tat-vaccinated healthy and HIV-1-infected volunteers
2003 D. M. Noonan, A. Gringeri, R. Meazza, O. Rosso, S. Mazza, M. Perja, H. Le Buanec, R. S. Accolla, A. Albini, S. Ferrini
Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum--an adjuvant to antiretroviral tritherapy
1999 D. Zagury, H. Lecoq, I. Gervi, H. Le Buanec, J. F. Zagury, B. Bizzini, A. Burny, P. Hermans, M. Perja, E. Santagostino, A. Gringeri
Tat toxoid as a component of a preventive vaccine in seronegative subjects
1999 A. Gringeri, E. Santagostino, M. Perja, H. Le Buanec, B. Bizzini, A. Lachgar, J. F. Zagury, J. Rappaport, A. Burny, R. C. Gallo, D. Zagury
A prospective clinical trial of implantable central venous access in children with haemophilia
1998 E. Santagostino, A. Gringeri, M. Perja, P.M. Mannucci
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients
1998 A. Gringeri, E. Santagostino, M. Perja, P.M. Mannucci, J.F. Zagury, B. Bizzini, A. Lachgar, M. Carcagno, J. Rappaport, M. Criscuolo, W. Blattner, A. Burny, R.C. Gallo, D. Zagury
A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoid
1998 H. Le Buanec, A. Lachgar, B. Bizzini, J.F. Zagury, J. Rappaport, E. Santagostino, M. Perja, A. Gringeri
High prevalence of serum cryoglobulins in multitransfused hemophilic patients with chronic hepatitis C
1998 E. Santagostino, M. Colombo, D. Cultraro, M. Perja, A. Gringeri, P.M. Mannucci
Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report
1996 A. Gringeri, E. Santagostino, M. Cusini, M. Perja, A. Marinoni, P.M. Mannucci, A. Burny, M. Criscuolo, W. Lu, J.M. Andrieru, J.P. Mbika, A. Lachgar, L.S. Fall, V. Chams, M. Feldman, P. Hermans, J.F. Zagury, B. Bizzini, M. Musicco, D. Zagury